EUSA PHARMA (UK) LIMITED IS A GLOBAL BIOPHARMACEUTICAL PART OF RECORDATI RARE DISEASES, THE BUSINESS UNIT DEDICATED TO RARE DISEASES IN THE RECORDATI GROUP
We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care.
- Helping the people with few or no options available is at the heart of everything we do.
- Eusa Pharma is part of Recordati Rare Diseases, the business unit dedicated to rare disease in the Recordati group. Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release here.
- We see a need. We work together. We don’t give up.